Anne M Filppula

9PUBLICATIONS
17CO-AUTHORS
PharmacogenomicsCharacterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsInstrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 03, 2026
Using Pharmacovigilance Data for Signal Detection of Drug Interactions for Rosuvastatin.

|Nov 01, 2024
Candesartan Has No Clinically Meaningful Effect on the Plasma Concentrations of Cytochrome P450 2C8 Substrate Repaglinide in Humans.

Mikael O W Piha, Kristiina Cajanus, Marica T Engström

|Oct 03, 2023
Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin.

Minna Lehtisalo, E Katriina Tarkiainen, Mikko Neuvonen

|Nov 29, 2022
Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4, and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A in vitro.

Marie-Noëlle Paludetto, Mika Kurkela, Helinä Kahma

|Aug 19, 2021
Translational aspects of cytochrome P450-mediated drug-drug interactions: A case study with clopidogrel.

Aleksi Tornio, Anne M Filppula, Janne T Backman

|Apr 12, 2019
Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations.

Anne M Filppula, Rezvan Parvizi, André Mateus

Pageof 2

Frequent Collaborators

6 joint publications

Janne T Backman

4 joint publications

Mikko Neuvonen

4 joint publications

Aleksi Tornio

4 joint publications

Mikko Niemi